Sphera Funds Management’s LAVA Therapeutics LVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-48,420
Closed -$61.5K 121
2025
Q1
$61.5K Sell
48,420
-77,908
-62% -$86.7K 0.02% 113
2024
Q4
$120K Sell
126,328
-20,129
-14% -$31.6K 0.02% 105
2024
Q3
$243K Sell
146,457
-221,125
-60% -$405K 0.04% 111
2024
Q2
$662K Hold
367,582
0.11% 110
2024
Q1
$1.22M Buy
+367,582
New +$809K 0.2% 93
2022
Q1
Sell
-137,857
Closed -$758K 85
2021
Q4
$758K Sell
137,857
-77,502
-36% -$508K 0.09% 88
2021
Q3
$1.27M Hold
215,359
0.13% 101
2021
Q2
$2.34M Buy
215,359
+1,465
+0.7% +$18.2K 0.21% 104
2021
Q1
$3.25M Buy
+213,894
New +$2.94M 0.3% 92

Other funds holding LVTX